Researching the Implementation of Over-the-Counter Oral Contraceptives
Purpose
The FDA's landmark approval of Opill, the first over-the-counter daily oral contraceptive in the US, represents an unprecedented opportunity to significantly expand contraceptive access. To realize this potential, key partners-including advocates, payers, pharmacy benefit managers, policymakers, pharmacy systems, scholars, and state agencies are actively working…
Source
Award
Dates
Eligibility
Supporting Links
Documents
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers